SCHEMBL6601970

SCHEMBL6601970

COC(=O)c1c(-c2cccc3ccccc23)cn(C(Cc2ccc3c(c2)OCO3)c2cnc[nH]2)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 4/20 0.41
FNTB P49356 4/20 0.41
PGGT1B P53609 3/20 0.41
CYP3A4 P08684 1/20 0.40
MAPT P10636 5/20 0.39
TSHR P16473 3/20 0.39
LMNA P02545 3/20 0.39
GAA P10253 2/20 0.39
MAPK1 P28482 2/20 0.39
HSD17B10 Q99714 2/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALOX15 P16050 1/20 0.39
ALDH1A1 P00352 4/20 0.37
RECQL P46063 1/20 0.37
KDM4E B2RXH2 5/20 0.37
HPGD P15428 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6600381 0.92 FNTA (0.41) FNTAFNTBPGGT1BCYP3A4MAPT
SCHEMBL6598190 0.87 FNTA (0.52) FNTAFNTBPGGT1BCYP3A4TSHR
SCHEMBL6599899 0.85 FNTA (0.42) FNTAFNTBPGGT1BCYP3A4MAPT
SCHEMBL6599881 0.83 FNTA (0.39) FNTAFNTBPGGT1BCYP3A4MAPT
SCHEMBL6598939 0.81 FNTA (0.51) FNTAFNTBPGGT1BCYP3A4GAA
SCHEMBL6596847 0.80 FNTA (0.49) FNTAFNTBPGGT1BCYP3A4MAPT
SCHEMBL7646033 0.77 FNTA (0.61) FNTAFNTBPGGT1BCYP3A4GAA
SCHEMBL6600150 0.76 FNTA (0.38) FNTAFNTBPGGT1BCYP3A4LMNA
SCHEMBL4955195 0.76 FNTA (0.60) FNTAFNTBPGGT1BCYP3A4LMNA
SCHEMBL6601972 0.75 FNTA (0.62) FNTAFNTBPGGT1BCYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1169320-B1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD (KR) 2004-09-22 EP disclosed
US-6511978-B1 For treating cancer, restenosis, atherosclerosis or viral infections LG LIFE SCIENCES, LTD. (KR) 2003-01-28 US disclosed